Celesio AG (CLSGn.DE)

CLSGn.DE on Xetra

16.80EUR
7:19am EDT
Price Change (% chg)

€-0.22 (-1.29%)
Prev Close
€15.80
Open
€17.00
Day's High
€17.06
Day's Low
€16.80
Volume
69,408
Avg. Vol
602,517
52-wk High
€18.00
52-wk Low
€12.81

CLSGn.DE

Chart for CLSGn.DE

About

Celesio AG is a Germany-based pharmaceutical distribution holding company. The Company, which is active in 27 countries, operates through three business divisions: Patient and Consumer Solutions, Pharmacy Solutions, and Manufacturer Solutions. The Patient and Consumer Solutions division offers retail and mail-order pharmacies,... (more)

Overall

Beta: 0.84
Market Cap (Mil.): €2,894.25
Shares Outstanding (Mil.): 170.10
Dividend: 0.30
Yield (%): 1.76

Financials

  CLSGn.DE Industry Sector
P/E (TTM): 29.26 17.12 39.77
EPS (TTM): 0.58 -- --
ROI: 2.33 9.99 66.51
ROE: 4.18 11.32 72.84
Search Stocks

BRIEF-Celesio shares post heavy losses after CEO sacked by owner Haniel

FRANKFURT, July 4 - Celesio AG : * Shares open down 4.3 percent after majority owner haniel sacks CEO

04 Jul 2013

Celesio fires CEO Pinger after management dispute

FRANKFURT - The supervisory board of Celesio has sacked the German drugs distributor's chief executive, Markus Pinger, with immediate effect after a falling out with the head of parent company Franz Haniel & Cie .

03 Jul 2013

UPDATE 2-Celesio fires CEO Pinger after management dispute

* Sources say tension grew after talks with U.S. investors

03 Jul 2013

Celesio fires CEO Pinger

FRANKFURT, July 3 - The supervisory board of Celesio has sacked the German drugs distributor's chief executive, Markus Pinger, with immediate effect, it said on Wednesday.

03 Jul 2013

Exclusive: U.S. drug firms vie to take stake in Celesio - sources

FRANKFURT - Two U.S. drugs distribution groups McKesson Corp and Cardinal Health Inc are both in talks to possibly take a stake in German drugs company Celesio , two industry sources familiar with the situation said.

01 Jul 2013

Haniel denies in talks with CVS to sell Celesio stake

DUESSELDORF, Germany - Diversified holding company Franz Haniel & Cie said on Wednesday it was not in talks with U.S. drugstore chain CVS to sell majority control over German drug distributor Celesio .

19 Jun 2013

UPDATE 1-Haniel denies in talks with CVS to sell Celesio stake

* CVS prepared to pay Celesio 2 bln eur for stake -magazine

19 Jun 2013

Haniel says not in talks with CVS to sell Celesio stake

DUESSELDORF, Germany, June 19 - Diversified holding company Franz Haniel & Cie on Wednesday said it was not in talks with U.S. group CVS to sell its 50.01 percent stake in German drug distributor Celesio, denying an earlier press report.

19 Jun 2013

Celesio Q1 core profit drops on competition in home market

FRANKFURT, May 14 - Celesio, Europe's largest drugs distributor, posted a steeper-than-expected decline in core earnings as harsh competition prompted a slide in prices charged to German pharmacies.

14 May 2013

Haniel says has no plans to cut Celesio stake

FRANKFURT, May 6 - Diversified holding company Franz Haniel & Cie. said it has no plans to further reduce its stake in German drugs distributor Celesio, rebuffing a media report.

06 May 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$472.00
Provider: Reuters Investment Profile
$20.00
Provider: Datamonitor
$175.00
Provider: GlobalData
$250.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks